Top in GI: Fecal microbiota transplantation, acute pancreatitis
Click Here to Manage Email Alerts
Fecal microbiota transplantation for recurrent Clostridioides difficile was safe and well tolerated among patients with inflammatory bowel disease, researchers reported. It was the top story in gastroenterology last week.
Another top story was about a study that showed patients with acute pancreatitis and COVID-19 may have a higher risk for multiorgan failure.
Read these and more stories in gastroenterology below:
FMT safe, well tolerated for recurrent CDI in IBD
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease (IBD) was safe and well tolerated and resulted in a high rate of C. difficile decolonization, according to a study published in Gastroenterology. Read more.
Patients with acute pancreatitis, COVID-19 at high risk for multiorgan failure
There may be a relationship between acute pancreatitis and COVID-19 that may lead to patients having a higher risk for multiorgan failure, morbidity and mortality, according to a study in Gastroenterology. Read more.
Atopic disease linked with increased risk for IBD
Individuals with atopic diseases such as asthma and atopic dermatitis appeared to be at higher risk for developing IBD, according to study results. Read more.
VIDEO: Edible colonoscopy prep shows efficacy in phase 2 trial
In this exclusive video, Corey A. Siegel, MD, MS, director of the Inflammatory Bowel Disease Center at the Dartmouth-Hitchcock Medical Center and co-founder of ColonaryConcepts, discusses the company’s edible colonoscopy prep that comes in the form of bars and smoothies. Read more.
Employer-related concerns of health care social media
Health care providers on social media are often held to higher standards than other individuals. Read more.